Glomus jugulare tumor: Tumor control and complications after stereotactic radiosurgery

摘要: Background We evaluated toxicity and long-term efficacy of stereotactic radiosurgery in patients with symptomatic or progressive glomus jugulare tumors. Methods Twenty-five consecutive (age, 30–88 years; 17 women, 8 men) who underwent the Leksell Gamma Knife (dose, 12–18 Gy) were prospectively followed. MRI clinical examinations performed at 6 months 1, 2, 3 years, then every 2 years. Results None tumors increased size, stable, decreased (median imaging follow-up, 35 months; range, 10–113 months). Symptoms subsided 15 (60%); vertigo occurred but balance improved vestibular training 37 11–118 No other new neuropathy cranial nerves V–XII developed. Conclusions Stereotactic can achieve excellent tumor control low risk morbidity treatment tumors. The lower safely tolerate a radiosurgical dose 12 to 18 Gy. © 2002 Wiley Periodicals, Inc. Head Neck 24: 332–339, 2002; DOI 10.1002/hed.10005